United States Pharmaceutical Third-party Logistics Market was valued at USD 36.04 Billion in 2022 and is projected to reach USD 54.51 Billion by 2030, growing at a CAGR of 5.2% from 2024 to 2030.
The U.S. pharmaceutical third-party logistics (3PL) market is experiencing remarkable growth, driven by the increasing complexity of pharmaceutical distribution and the rising demand for specialized supply chain solutions. In 2024, the market was valued at approximately $45.37 billion and is projected to expand at a compound annual growth rate (CAGR) of 8.90% from 2025 to 2030, reaching an estimated $75.41 billion by 2030. This growth is largely attributed to the escalating need for efficient management of temperature-sensitive products, such as biologics and vaccines, which require stringent cold chain logistics.
Pharmaceutical companies are increasingly outsourcing logistics functions to 3PL providers to streamline operations, improve efficiency, and reduce costs. This trend allows companies to focus on core competencies like research and development while leveraging the expertise of specialized logistics providers. For instance, McKesson Corporation reported a 19% increase in sales within its U.S. pharmaceutical segment in the previous year, highlighting the growing reliance on third-party logistics services. However, recent reports indicate that McKesson's third-quarter revenues fell short of estimates, primarily due to lower-than-expected sales in its pharmaceutical segment, underscoring the challenges within the supply chain.
Technological advancements play a pivotal role in enhancing the efficiency and security of pharmaceutical logistics. The integration of real-time tracking systems, automated warehouses, and cloud-based platforms has significantly improved operational transparency and efficiency. These technologies are essential for managing the complexities of cold chain logistics, ensuring that temperature-sensitive products maintain their efficacy throughout the distribution process. The COVID-19 pandemic has further emphasized the importance of robust logistics infrastructure, particularly for the distribution of vaccines requiring ultra-low temperatures.
Reverse logistics has become an increasingly important aspect of the pharmaceutical supply chain. The growing number of product recalls and the need to manage unused drug stockpiles have heightened the focus on efficient return, disposal, and recycling processes. Implementing effective reverse logistics systems is crucial for maintaining regulatory compliance and addressing environmental concerns, thereby contributing to the overall efficiency of the supply chain.
The competitive landscape of the U.S. pharmaceutical 3PL market features several key players, including McKesson Corporation, Cardinal Health, and Cencora Corporation. These companies offer tailored solutions to meet the unique demands of pharmaceutical distribution, emphasizing the importance of strategic partnerships in navigating the complexities of the pharmaceutical supply chain. As the market continues to evolve, the role of 3PL providers in ensuring the timely and secure delivery of pharmaceutical products cannot be overstated.
Get an In-Depth Research Analysis of the US Pharmaceutical Third-party Logistics Market Size And Forecast [2025-2032]
DHL
FedEx
Kuehne + Nagel International AG
United Parcel Service
CH Robinson Worldwide
CEVA Logistics
DB Schenker
Agility Logistics
Expeditors International of Washington
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Pharmaceutical Third-party Logistics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Pharmaceutical Third-party Logistics Market
Transportation and Storage
Package and Distribution Management
Inventory Management
Temperature-controlled Logistics
Reverse Logistics
Pharmaceutical Manufacturers
Biopharmaceutical Companies
Clinical Research Organizations (CROs)
Medical Device Companies
Healthcare Providers and Institutions
Air Freight
Sea Freight
Road Freight
Rail Freight
Intermodal Transportation
Prescription Medicines
Over-the-counter (OTC) Drugs
Biologics
Specialty Medications
Generic Drugs
Bottles
Blister Packs
Vials
Ampoules
Bulk Packaging
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Pharmaceutical Third-party Logistics Market Research Analysis
1. Introduction of the US Pharmaceutical Third-party Logistics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Pharmaceutical Third-party Logistics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Pharmaceutical Third-party Logistics Market, By Type
6. US Pharmaceutical Third-party Logistics Market, By Application
7. US Pharmaceutical Third-party Logistics Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Pharmaceutical Third-party Logistics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/